During a conference call on Wednesday (March 7) with investors, LGC Capital (TSXV:LG) provided a clearer picture of its international efforts, the pressure on its South African deal and the options the company is contemplating when it comes to investing in the cannabis market.

John McMullen, CEO of LGC started the call by stating the company currently has over $16 million in the bank at its disposal with an additional $18.7 million coming by way of the exercise of all outstanding share warrants.


According to McMullen, the company has more than enough cash to fund the current investments in the production of cannabis and pursue new ones.

“Just to be clear, we do not need to or intend to raise another dollar as of today, based on our existing projects and other international projects,” McMullen said during the call.

McMullen credited Cormark Securities for continuing to act as underwriters for LGC’s bought deals and not wavering despite the entire industry facing a market correction.

“We believe our investee companies can reach an annualized net production to LGC Capital of 40,000 to 80,000 kilograms in 2019-2020,” McMullen told shareholders.

South African deal opportunity facing delays

McMullen also provided an update on the delay of its South African partnership with House of Hemp.

Last year LGC signed a letter of intent to acquire 60 percent of House of Hemp a company in South Africa. McMullen said this deal lives on the promise that the South African cannabis company is able to deliver a commercial license in the country.

“While we expected the licensing and legislative process in South Africa would move quite quickly in the context of what was happening in many governments around the world, this has not been the case,” he said.

“The reality is that to date the government of South Africa has not issued such a license to House of Hemp or to any other company in its jurisdiction,” McMullen told investors.

He confirmed LCG will not move forward with the investment deal until their conditions are met by House of Hemp.

As part of the questions and answer period of the call, one investor asked the group which of the partnerships were concrete and fully active.

McMullen answered by saying the AAA Trichomes in Canada and Little Green Pharma in Australia are the only current active partnerships. However, he added LGC will be providing updates in the near future on its proposed partnerships in Jamaica and with other companies.

Investor Takeaway

“We generally invest in private, early stage pre-revenue cannabis companies. We invest in pre-growth companies because the valuations increase exponentially once these companies begin full-scale production,” McMullen said of the company’s vision in the market.

Year-to-date, LGC has decreased 56 percent to close at $0.22 on Wednesday, resulting in a $0.28 loss per share since the start of the year.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.

Keep reading... Show less

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less